Anna H Larsson
1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Prognostic value of HER3 and HER2 alterations in colorectal cancer: Relationship with sidedness, KRAS and BRAF mutation status
2017) European Society of Medical Oncologys annual congress(
- Contribution to conference › Abstract
-
Mark
The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite : A cohort study
(
- Contribution to journal › Article
- 2016
-
Mark
Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Discovery and validation of podocalyxin-like protein as a prognostic biomarker in colorectal cancer
(
- Thesis › Doctoral thesis (compilation)
- 2013
-
Mark
Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases
(
- Contribution to journal › Article
-
Mark
Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.
(
- Contribution to journal › Article
- 2012
-
Mark
Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
(
- Contribution to journal › Article
- 2011
-
Mark
Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.
(
- Contribution to journal › Article